Adaptimmune Therapeutics Plc (ADAPY)

0.0278 0.00 (0.00%) USD  |  OTCM  |  Dec 26, 16:00
More

Adaptimmune Therapeutics Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for ADAPY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Autolus Therapeutics Plc Upgrade
NuCana Plc --
Mereo BioPharma Group Plc Upgrade
Bicycle Therapeutics Plc --